
Biohaven reports Q2 2026 net loss of $137.3M, cash and marketable securities $267.9M
<a href="https://news.google.com/rss/articles/CBMi2wFBVV95cUxQUVdsRTB2ZkVwMmtpNGFwNVFNcUw3Q25PZEIxemlSOFhDRTBkbFJsSlRQSlh3Rm1vMER4bFdpbUNzclRZM1hwN2c2dUN3bHIxMmg2LUZ3Zl8xbjlCWkNfRTFoeGNUc3NLNmpXdnZtcWp0SEVQYlQzeUdsZGViQXRFZjU1bFRTc2dmUTV0WTE1eUROd2xPLW5XYUxCNFpoVGhHSU9zTklkZmxlZmN6VlpUUjNoejVVbUl6TWpSZXgzRzNvaVpDNGxuMWhLVkpueHYyS2VjNENYMEJQRzQ?oc=5" target="_blank">Biohaven reports Q2 2026 net loss of $137.3M, cash and marketable securities $267.9M</a>&nbsp;&nbsp;<font color="#6f6f6f">TradingView</font>

